128 related articles for article (PubMed ID: 37440274)
1. Mechanism of Xiaoyao San in treating non-alcoholic fatty liver disease with liver depression and spleen deficiency: based on bioinformatics, metabolomics and
Ruan X; Zhang X; Liu L; Zhang J
J Biomol Struct Dyn; 2024 Jul; 42(10):5128-5146. PubMed ID: 37440274
[TBL] [Abstract][Full Text] [Related]
2. A unique insight for Xiaoyao San exerts antidepressant effects by modulating hippocampal glucose catabolism using stable isotope-resolved metabolomics.
Wu WZ; Ling-Hu T; Zhao YH; Zhao WD; Ji C; Tian JS; Ren Y; Qin XM
J Ethnopharmacol; 2023 Jan; 300():115702. PubMed ID: 36099982
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of Xiaoyao San in treatment of depression,breast hyperplasia,and functional dyspepsia based on network pharmacology].
Wei FX; Liu HL; Fan YH; Li XQ; Zhao SJ; Qin XM; Liu XJ
Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(16):4230-4237. PubMed ID: 34467737
[TBL] [Abstract][Full Text] [Related]
4. Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.
Chen C; Yin Q; Tian J; Gao X; Qin X; Du G; Zhou Y
J Ethnopharmacol; 2020 Mar; 249():112432. PubMed ID: 31790818
[TBL] [Abstract][Full Text] [Related]
5. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
[TBL] [Abstract][Full Text] [Related]
6. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte steatosis activates macrophage inflammatory response accelerating atherosclerosis development.
Li Y; Wu X; Pan J; Gong L; Min D
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 52(6):751-765. PubMed ID: 38105677
[TBL] [Abstract][Full Text] [Related]
9. Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of Xiaoyaosan.
Liu X; Wei F; Liu H; Zhao S; Du G; Qin X
J Ethnopharmacol; 2021 Mar; 268():113549. PubMed ID: 33152435
[TBL] [Abstract][Full Text] [Related]
10. Integrating Metabolomics and Network Pharmacology to Explore the Mechanism of Xiao-Yao-San in the Treatment of Inflammatory Response in CUMS Mice.
Zhang Y; Li XJ; Wang XR; Wang X; Li GH; Xue QY; Zhang MJ; Ao HQ
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004472
[TBL] [Abstract][Full Text] [Related]
11. Xiaoyao San attenuates hepatic steatosis through estrogen receptor α pathway in ovariectomized ApoE-/- mice.
Hu T; Wei M; Hong G; Qi T; Xiang Y; Yang Y; Yi Y
J Ethnopharmacol; 2022 Jan; 282():114612. PubMed ID: 34496266
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway.
Xu Y; Chen W; Chen Z; Huang M; Yang F; Zhang Y
Drug Des Devel Ther; 2021; 15():753-767. PubMed ID: 33654381
[TBL] [Abstract][Full Text] [Related]
13. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L
J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728
[TBL] [Abstract][Full Text] [Related]
14. Protective Effect of Fuzi Lizhong Decoction against Non-alcoholic Fatty Liver Disease via Anti-inflammatory Response through Regulating p53 and PPARG Signaling.
Yang J; Ma W; Mei Q; Song J; Shu L; Zhang S; Li C; An L; Du N; Shi Z
Biol Pharm Bull; 2020; 43(11):1626-1633. PubMed ID: 33132309
[TBL] [Abstract][Full Text] [Related]
15. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Li S; Wu X; Ma Y; Zhang H; Chen W
J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
[TBL] [Abstract][Full Text] [Related]
16. A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors.
Nie H; Deng Y; Zheng C; Pan M; Xie J; Zhang Y; Yang Q
J Cell Mol Med; 2020 May; 24(9):5168-5184. PubMed ID: 32189432
[TBL] [Abstract][Full Text] [Related]
17. Effects of Xiaoyao San on exercise capacity and liver mitochondrial metabolomics in rat depression model.
Zhao W; Ji C; Zheng J; Zhou S; Tian J; Han Y; Qin X
Chin Herb Med; 2024 Jan; 16(1):132-142. PubMed ID: 38375048
[TBL] [Abstract][Full Text] [Related]
18. Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease.
Zhang X; Zhang J; Zhou Z; Xiong P; Cheng L; Ma J; Wen Y; Shen T; He X; Wang L; Zhang Y; Xiao C
J Ethnopharmacol; 2024 May; 325():117828. PubMed ID: 38325669
[TBL] [Abstract][Full Text] [Related]
19. Antipyretic effects of Xiangqin Jiere granules on febrile young rats revealed by combining pharmacodynamics, metabolomics, network pharmacology, molecular biology experiments and molecular docking strategies.
He X; Cui J; Li H; Zhou Y; Wu X; Jiang C; Xu Z; Wang R; Xiong L
J Biomol Struct Dyn; 2024 Jan; ():1-18. PubMed ID: 38197809
[TBL] [Abstract][Full Text] [Related]
20. Stable Isotope Tracer Technique and Network Pharmacology to Reveal Antidepressant Targets and Active Components of Xiaoyao San.
Tian J; Wang X; Wu W; Zhao Y; Ling-Hu T; Qin X
Chem Biodivers; 2024 Apr; 21(4):e202301736. PubMed ID: 38451006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
